Published in Microbiol Spectr on October 01, 2015
Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis (2005) 9.23
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis (2012) 2.43
Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med (2004) 2.17
Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis (2008) 2.06
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol (2007) 1.97
Microbiology of animal bite wound infections. Clin Microbiol Rev (2011) 1.96
Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med (2006) 1.82
Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis (2012) 1.42
Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. isolated from human clinical infections. J Clin Microbiol (2006) 1.38
Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev (2013) 1.37
Bacteriology of a bear bite wound to a human: case report. J Clin Microbiol (2004) 1.37
A central role for venom in predation by Varanus komodoensis (Komodo Dragon) and the extinct giant Varanus (Megalania) priscus. Proc Natl Acad Sci U S A (2009) 1.36
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis (2010) 1.32
Emergence of fluoroquinolone resistance among Bacteroides species. J Antimicrob Chemother (2003) 1.29
Pelvic abscess due to Ochrobactrum intermedium [corrected] in an immunocompetent host: case report and review of the literature. J Clin Microbiol (2006) 1.24
Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Clin Infect Dis (2003) 1.23
Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera. J Clin Microbiol (2005) 1.22
Peptoniphilus coxii sp. nov. and Peptoniphilus tyrrelliae sp. nov. isolated from human clinical infections. Anaerobe (2011) 1.17
Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods. Anaerobe (2011) 1.14
In vitro activities of CB-183,315, vancomycin, and metronidazole against 556 strains of Clostridium difficile, 445 other intestinal anaerobes, and 56 Enterobacteriaceae species. Antimicrob Agents Chemother (2011) 1.09
Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria. Antimicrob Agents Chemother (2012) 1.09
16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Fusobacterium. Int J Syst Evol Microbiol (2002) 1.08
Blood cultures for community-acquired pneumonia: can we hit the target without a shotgun? Ann Emerg Med (2005) 1.08
Acute bacterial skin infections: developments since the 2005 Infectious Diseases Society of America (IDSA) guidelines. J Emerg Med (2013) 1.08
Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents. J Antimicrob Chemother (2004) 1.07
In vitro activities of daptomycin, vancomycin, and penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes. Antimicrob Agents Chemother (2006) 1.04
In vitro activity of ceftazidime-NXL104 against 396 strains of beta-lactamase-producing anaerobes. Antimicrob Agents Chemother (2011) 0.99
Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor. Anaerobe (2003) 0.98
Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis (2012) 0.97
Synergistes group organisms of human origin. J Clin Microbiol (2006) 0.94
Infective endocarditis associated with spondylodiscitis and frequent secondary epidural abscess. Surg Neurol (2007) 0.93
Antimicrobial prophylaxis for wounds and procedures in the emergency department. Infect Dis Clin North Am (2008) 0.93
Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. Int J Antimicrob Agents (2011) 0.91
Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am (2008) 0.89
Association Between Appendectomy and Clostridium difficile Infection. J Clin Med Res (2012) 0.88
16S-23S rRNA gene internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Porphyromonas. Int J Syst Evol Microbiol (2005) 0.88
Difficulty in the identification and differentiation of clinically relevant Ochrobactrum species. J Med Microbiol (2007) 0.87
Emergency department management of meningitis and encephalitis. Infect Dis Clin North Am (2008) 0.87
Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile. Diagn Microbiol Infect Dis (2011) 0.86
In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. Int J Antimicrob Agents (2006) 0.86
Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria. J Antimicrob Chemother (2009) 0.85
Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1). Emerg Infect Dis (2016) 0.85
Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples. J Clin Microbiol (2013) 0.85
Decision instrument for the isolation of pneumonia patients with suspected pulmonary tuberculosis admitted through US emergency departments. Ann Emerg Med (2008) 0.83
Periodontal bacteria in rabbit mandibular and maxillary abscesses. J Clin Microbiol (2002) 0.83
Fluoroquinolones and anaerobes. Clin Infect Dis (2006) 0.83
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis. Ann Pharmacother (2005) 0.82
Fusobacterium canifelinum sp. nov., from the oral cavity of cats and dogs. Syst Appl Microbiol (2004) 0.82
Broth microdilution and disk diffusion tests for susceptibility testing of Pasteurella species isolated from human clinical specimens. J Clin Microbiol (2005) 0.82
Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum. Antimicrob Agents Chemother (2003) 0.82
Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens. Int J Antimicrob Agents (2007) 0.82
A review of three cases of Clostridium aldenense bacteremia. Anaerobe (2010) 0.80
The times they are a-changin': new antibacterials for skin and skin structure infections. Am J Clin Dermatol (2015) 0.80
Biological terrorism. Infect Dis Clin North Am (2008) 0.80
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection. J Antimicrob Chemother (2002) 0.79
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures. J Med Microbiol (2005) 0.78
Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens. Anaerobe (2007) 0.78
Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates. Anaerobe (2007) 0.78
Clostridium difficile: improving the prevention paradigm in healthcare settings. Expert Rev Anti Infect Ther (2014) 0.78
First report of Parabacteroides goldsteinii bacteraemia in a patient with complicated intra-abdominal infection. Anaerobe (2010) 0.77
Update on emerging infections: news from the Centers for Disease Control and Prevention. Travel-associated dengue infections--United States, 2001-2004. Ann Emerg Med (2005) 0.77
Update on emerging infections from the Centers for Disease Control and Prevention. Multistate outbreak of mumps--United States, January 1-May 2, 2006. Ann Emerg Med (2006) 0.77
Methicillin-resistant Staphylococcus aureus infections. N Engl J Med (2007) 0.77
Successful treatment of Mycobacterium terrae complex infection of the knee. J Clin Rheumatol (2012) 0.77
Diagnosis and management of pneumonia in the emergency department. Infect Dis Clin North Am (2008) 0.77
In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species. Antimicrob Agents Chemother (2012) 0.76
Genetic determinant of intrinsic quinolone resistance in Fusobacterium canifelinum. Antimicrob Agents Chemother (2005) 0.76
Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. Diabetes Metab Res Rev (2015) 0.76
Community-acquired bacterial meningitis. N Engl J Med (2006) 0.75
Mobilization and prevalence of a Fusobacterial plasmid. Plasmid (2009) 0.75
Activity of Ceftaroline against Aerobic Gram-Positive and Gram-Negative Pathogens: Effect of Test Method Variability. ISRN Microbiol (2011) 0.75
Combating the ascendancy of MRSA: early efforts in eradication of colonization. Curr Infect Dis Rep (2007) 0.75
Update on emerging infections: news from the Centers for Disease Control and Prevention. Shigella flexneri serotype 3 infections among men who have sex with men--Chicago, Illinois 2003-2004. Ann Emerg Med (2006) 0.75
Infectious disease emergencies. Preface. Infect Dis Clin North Am (2008) 0.75
Therapy of Clostridium difficile infection: perspectives on a changing paradigm. Expert Opin Pharmacother (2013) 0.75
Review of the in vitro activity and potential clinical efficacy of levofloxacin in the treatment of anaerobic infections. Anaerobe (2003) 0.75
Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections. Diagn Microbiol Infect Dis (2013) 0.75
EM in the 'black forest': Nagorno Karabagh. Am J Emerg Med (2004) 0.75
Intrathecal amphotericin B: A 60 year experience in treating coccidioidal meningitis. Clin Infect Dis (2016) 0.75